Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate) Drug Interactions
115 major drug interactions
722 moderate drug interactions
51 minor drug interactions
Common medications checked in combination with Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
Ambien (zolpidem)- Ativan (lorazepam)
- baclofen
- clonazepam
- Colace (docusate)
- Cymbalta (duloxetine)
- Dexilant (dexlansoprazole)
- Flomax (tamsulosin)
- levothyroxine
- Lyrica (pregabalin)
- Nasonex (mometasone nasal)
- Nexium (esomeprazole)
- omeprazole
- Protonix (pantoprazole)
- simvastatin
- Singulair (montelukast)
- Topamax (topiramate)
- VESIcare (solifenacin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Check for interactions with Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
Type in a drug name and select a drug from the list.
You should also know about...
Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate) alcohol/food Interactions
There is 1 alcohol/food interaction with Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate) disease Interactions
There are 12 disease interactions with Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate) which include:
- Crystalluria
- Liver Disease
- Methemoglobinemia In G-6-Pd
- Gi Toxicity
- Renal Dysfunction
- Reye's Syndrome
- Renal Dysfunction
- Anemia
- Coagulation
- Dialysis
- G-6-Pd Deficiency
- Hepatotoxicity
See also...
- Side Effects of Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate) Consumer Information
Drug Interaction Classification
The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2013 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
